Business Wire

VidMob Raises $50 Million Series C to Accelerate Broad Adoption of its Platform for Intelligent Creative

Share

VidMob, the leading platform for Intelligent Creative, announced today that it has closed its Series C financing, raising $50 million in expansion capital from a group of funds, strategic investors, and influential companies in the creative technology space. The new round will support VidMob’s global expansion, new e-commerce initiatives, ongoing investments into advanced technology, and data science to help marketers maximize the value of advertising creative.

The new round includes participation from Adobe, the global leader in digital creativity software, Shutterstock, a leading global creative platform offering full-service solutions, high-quality content, and tools for brands, businesses and media companies, Drive by DraftKings, a venture capital firm investing in sports tech and entertainment, the Spruce House Partnership, Prefix Capital, BuildGroup, Interlock Partners, Macanta, and key industry and tech leaders like Michael Kassan, Nick Brien, and Thomas Tull, among others. César Melo, former president at Mondelez and PepsiCo, CEO at Foster Grant and VP at Colgate-Palmolive is also investing and joining the board as an advisor. When combined with previous rounds, the company has now raised nearly $100 million to expand on its groundbreaking platform for Intelligent Creative.

VidMob has pioneered AI to measure creative performance so marketers can optimize ad design for more efficient and impactful campaigns. VidMob’s Intelligent Creative platform unifies creative and data and connects brands to a global network of elite content creators trained on continuously updated best practices for every digital media channel and next-gen ad format. Originally focused on partnerships with the major social platforms, VidMob has expanded its distribution to include leaders in the programmatic web and CTV / OTT.

“Every other area of enterprise operations has been positively impacted by software platforms -- increasing efficiency and using data to bring intelligence to decision-making,” said Alex Collmer, the founder and CEO of VidMob. “This financing and these new relationships will be a powerful accelerant in our commitment to build and deploy a platform that helps marketers transform for the needs of the future, while respecting the irreplaceable role of human creativity and never losing sight of our mission to evolve creativity for the better.”

“We were blown away by the power of VidMob’s learning models for Intelligent Creative,” said Owen Van Natta of Prefix Capital, and former VP of Worldwide Business and Corporate Development at Amazon. “VidMob’s ‘services-in-the-loop’ model, coupled with the integration of their creative marketplace is a construct that is unrivaled in its learning capability.”

“Creative performance has gone unmeasured while the advertising industry has focused on technologies to measure return on media spend, said Lynda Clarizio, former President of Nielsen US Media and an investor in the financing. “VidMob’s platform for Intelligent Creative solves this long unmet need by offering marketers a scalable platform across media to measure the impact of creative on achieving campaign objectives and to optimize and improve the creative process.”

Former Executive Vice-Chairman of Omnicom Media Group, and previously global CEO of OMD, Aegis Media and MEC, Mainardo de Nardis, who also invested in the financing, added, “I was privileged to be part of a group of people who transformed the full-service advertising model, separating media from creative, at a time when advertisers demanded independent strategic media services. That was 30 years ago. Today, I am happy to be doing the exact opposite. It no longer serves marketers well to silo creative and media practices, both equally important in terms of optimization. The power of VidMob’s data-driven platform lies in its ability to unite media and creative, bringing together the many layers of the industry, from advertising platforms and brands to agencies.”

Consumer brand veteran César Melo added "as a commercial leader, I was always looking to create a more efficient content ecosystem in which faster, smarter, data-informed and more cost-effective content could be created to surround the consumer around the world and build brands differently. When I discovered VidMob while trying to do this at PepsiCo, I was blown away by the combination of talented human creativity and technology. And the more I see, the more I like. VidMob is creating a new category, “Intelligent Creative.”

VidMob is the only company to have earned a creative partner badge from every leading social and digital media platform, and its client roster includes many of the world’s most forward-thinking marketing organizations such as Johnson & Johnson and Colgate Palmolive.

A purpose-driven company since Day 1, VidMob donates a portion of every dollar earned to fund Intelligent Creative for non-profit organizations through its 501c(3) VidMob Gives. VidMob Gives has supported 84 NPOs across 63 countries. In 2020, VidMob Gives helped raise over $20 million in partnership with organizations including the CDC Foundation, UN Foundation, Equality Now and the Ronald McDonald House.

About VidMob

VidMob is the world’s first platform for Intelligent Creative that provides an end-to-end solution to help brands improve their marketing results by unifying creative and data. VidMob is the only company in the world to receive a certified creative marketing partner badge from every major social and digital platform. A portion of every dollar VidMob receives is used to fund pro bono creative services for non-profits through its 501(c)(3) VidMob Gives. Most recently, the company was included in Inc. magazine's annual list of the Best Workplaces for 2020 and VidMob received the 2020 Creative Intelligence Technology Innovation Award from Frost & Sullivan. Learn more about VidMob at www.vidmob.com and VidMob Gives at vidmob.gives.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Tessa Flanagan
+44 (0)2036421124
Vidmob@teamgingermay.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 20268.12.2025 09:00:00 EET | Press release

Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that the company will present more than 20 clinical and non-clinical abstracts and posters spanning spasticity, movement disorders, and neurotoxin science at the TOXINS 2026 8th International Conference, taking place January 14–17, 2026, in Madrid, Spain. These presentations underscore the company’s commitment to addressing unmet needs in neurological disorders. “Our research reflects a relentless focus on improving patient outcomes through innovation in neurotoxin science,” said Dr. Stefan Albrecht, Chief Scientific and Medical Officer at Merz Therapeutics. “By presenting these new data at TOXINS 2026, we aim to foster scientific exchange and advance treatment strategies that address real-world challenges for patients and clinicians.” Merz Therapeutics will share new findings reflecting its continued dedication to advancing neurotoxin science. These include: Lower Limb Spasticity Incobotulinumto

Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 08:05:00 EET | Press release

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additionally, Galderma and L’Oréal aim at exploring additional scientific research projects of mutual interest. This ongoing collaboration brings together Galderma’s scientific leadership i

Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 05:37:00 EET | Press release

Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the National Institute of Standards and Technology (NIST) show that many commercial facial recognition algorithms have significantly higher error rates for women and people of colour largely due to underrepresentation in datasets AI algorithms are trained on. Biased algorithms lead to unfair denials of service and create security vulnerabilities. The competition at the Conference on Neural Information Processing Systems, among the world’s most prestigious AI con

Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 01:00:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemia (CLL), highlighting the foundational potential of this medicine. “The data we’re presenting at ASH 2025 are redefining what physicians can expect from sonrotoclax as a next-generation BCL2 inhibitor,” said Amit Agarwal, M.D., Ph.D., Chief Medical

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 18:00:00 EET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye